To provide a brief background, the TRAILBLAZER-ALZ 2 LTE study was a Phase 3, double-blind extension of the original ...

The microfinance industry, once heralded as a tool for financial inclusion and finding wealth at the bottom of the pyramid, ...

A new report from RAND has found that nearly 12% of people in the United States have taken a type of weight loss drug known ...

We recently published 12 Best Healthcare Stocks to Buy Under $30. OPKO Health, Inc. (NASDAQ:OPK) is one of the best ...

Going up against these giants is no small challenge, but Viking is, so far, holding its own. And if it can play its cards ...

Only one of these growth stocks is up big so far in 2025. But all three could be huge winners over the next few years.

Structure Therapeutics has dropped over 55% as its GLP-1 pill targets obesity, yet analysts remain bullish with high price ...

With more people in Acadiana using GLP-1 medications like Ozempic and Wegovy to support their weight loss journeys, many are ...

The board-certified plastic and reconstructive surgeons at Ochsner Health are seeing a surge in patients seeking body ...

It’s no secret that obesity is becoming an epidemic in the United  States. It’s estimated that by 2030, 50 percent of ...

Hims & Hers saw 73% revenue growth, driven by subscriber gains and ARPU hikes. Read here for an in-depth investment analysis ...

State Treasurer Brad Briner has said the plan faced a $500 million deficit in 2026 without major changes. Increasing premiums ...